Detected ·
Ollin Biosciences
$330M—
Ollin Biosciences raised $330M in Series B led by TCGX and ARCH Venture Partners to advance OLN324 into global Phase 3 development and progress OLN102 toward the clinic.
- Website
- ollin.bio
- Amount
- $330 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-24 16:11:07 UTC
- Signal ID
- 82cf6802-997f-4858-bc27-46d500b31eab
As the API returns it
{
"id": "82cf6802-997f-4858-bc27-46d500b31eab",
"created_at": "2026-06-24T16:11:07.962408Z",
"company_name": "Ollin Biosciences",
"company_website_url": "ollin.bio",
"company_linkedin_url": "https://www.linkedin.com/company/ollin-biosciences",
"event_type": "funding",
"funding_amount": 330000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Ollin Biosciences raised $330M in Series B led by TCGX and ARCH Venture Partners to advance OLN324 into global Phase 3 development and progress OLN102 toward the clinic.*"
}